MISSISSAUGA, Ontario / May 22, 2025 / Business Wire / MedX Health Corp. (“ MedX ” or the “ Company ”) (TSX-V: MDX ) is pleased to announce that, further to its Press Release dated April 7, 2025, announcing an Initial Closing, it has completed a further Closing of the Non-brokered Private Placement to accredited investors originally announced in its Press Release dated February 25, 2025. The Further Closing comprised the... Read More

MISSISSAUGA, Ontario / May 21, 2025 / Business Wire / MedX Health Corp. (“MedX” or the “Company”) (TSXV: MDX), a global leader in teledermatology, is pleased to announce a strategic collaboration in the Italian healthcare market between Vitamed Biomedical, a MedX commercial partner in Italy, and Medispa, a leading Italian healthcare company delivering innovative digital solutions for prevention, wellness, and healthcare.... Read More

MISSISSAUGA, Ontario / May 15, 2025 / Business Wire / MedX Health Corp. (“ MedX ” or the “ Company ”) (TSXV: MDX ), the global leader in teledermatology solutions, is pleased to announce the signing of a commercial contract with Health Partners Group Ltd (“ HPG ” or “ Health Partners Group ”), the United Kingdom’s largest occupational health services provider. This agreement follows the successful completion of a pilot... Read More

MISSISSAUGA, Ontario / May 06, 2025 / Business Wire / MedX Health Corp. (“ MedX ” or the “ Company ”) (TSX-V: MDX ) is pleased to announce that, further to its Press Release dated April 7, 2025, when it announced the Initial Closing of the Non-brokered Private Placement to accredited investors originally announced in its Press Release dated February 25, 2025, it has made application to the TSX Venture Exchange for an... Read More

MISSISSAUGA, Ontario / Apr 07, 2025 / Business Wire / MedX Health Corp. (“ MedX ” or the “ Company ”) (TSX-V: MDX ) is pleased to announce that it has completed the Initial Closing of the Non-brokered Private Placement to accredited investors announced in its Press Release dated February 25, 2025. The Initial Closing comprised the issuance of 13,500,000 Units (as described below) and raised cash proceeds of $945,000. A cash... Read More

MISSISSAUGA, Ontario / Feb 25, 2025 / Business Wire / MedX Health Corp. (“ MedX ” or the “ Company ”) (TSX-V: MDX ) is pleased to announce that it is proposing to raise up to $2,500,000 by way of a Non-Brokered Private Placement of up to 35,714,858 Units at $0.07 per Unit (“Unit”). Each Unit will be comprised of One (1) fully paid common share and One (1) Share Purchase Warrant (“ Warrant ( s )”), exercisable to purchase One... Read More

MISSISSAUGA, Ontario / Dec 12, 2024 / Business Wire / In its Press Release dated October 22, 2024, MedX Health Corp. (“ MedX ” or the “ Company ”) (TSX-V: MDX ) announced that it had obtained final TSXV Acceptance for extension of the Maturity Date of $2,650,000 out of $3,700,000 of then outstanding Convertible Loan Notes (“ Series I Notes ”) from December 31, 2023 to December 31, 2025 (the “ Extension ”), and that it may... Read More

MISSISSAUGA, Ontario / Oct 23, 2024 / Business Wire / MedX Health Corp. (“ MedX ” or the “ Company ”) (TSX-V: MDX) announces that further to its Press Release dated August 6, 2024, the TSXV issued a Final Acceptance Letter dated August 14, 2024, in respect of the Amendment to the remaining outstanding $3,700,000 of the Series I Loan Notes issued in 2021, by the Extension of the Maturity Date from December 31, 2023, to... Read More

MISSISSAUGA, Ontario / Aug 06, 2024 / Business Wire / MedX Health Corp. (“ MedX ” or the “ Company ”) (TSX-V: MDX) announces that it has applied for Final Acceptance from the TSXV following final Closing of the non-brokered Private Placement, which was previously announced on May 1, 2024. Closings took place on June 3, 2024 and July 24, 2024. The placement, to accredited investors, raised a total of $550,000, by issuance of... Read More

MISSISSAUGA, Ontario / Jun 26, 2024 / Business Wire / MedX Health Corp. (“ MedX ” or the “ Company ”) (TSX-V: MDX) announces that it has completed the Initial Closing of the Private Placement originally announced on May 1, 2024, by issuance of 7,142,856 Units (as described below) to raise $500,000. A cash commission of $2,800 was paid in respect of the Initial Closing. The Company further announces that, subject to... Read More

MISSISSAUGA, Ontario / May 31, 2024 / Business Wire / MedX Health Corp. (“ MedX ” or the “ Company ”) (TSX-V: MDX) announced today that, subject to acceptance by the TSX-V, the ultimate Closing Date for the non-brokered Private Placement of up to $2 million, which was previously announced on May 1, 2024, will be extended by up to 30 days. The Company has already received Conditional Acceptance for the placement from the... Read More

MISSISSAUGA, Ontario / May 01, 2024 / Business Wire / MedX Health Corp. (“ MedX ” or the “ Company ”) (TSX-V: MDX ) is pleased to announce that it is proposing to raise up to $2,000,000 by way of a Non-Brokered Private Placement of up to 28,571,428 Units at $0.07 per Unit (“Unit”). A Price Reservation Form for this proposed placement was filed with the TSXV on April 19, 2024. Each Unit will be comprised of One (1) fully paid... Read More

Health Partners, the UK’s largest non-hospital private healthcare services provider, with over two million patients across 550+ corporate, insurance and government clients, announced its intention to partner with MedX after successfully piloting MedX’s DermSecure ® Screening Platform. MISSISSAUGA, Ontario / Feb 28, 2024 / Business Wire / MedX Health Corp. (" MedX " or the " Company ") (TSXV: MDX ), a global leader in... Read More

Highlights: Dr. Cohen provides regular melanoma-related commentary to various media, including CTV, Global and CBC news outlets. MISSISSAUGA, Ontario / Jan 25, 2024 / Business Wire / MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE: MDX) is pleased to announce that it has appointed Dr. Paul Cohen, a board-certified dermatologist and Fellow of the Royal College of Physicians and Surgeons of Canada, as Medical... Read More

MISSISSAUGA, Ontario / Dec 12, 2023 / Business Wire / MedX Health Corp. (“ MedX ” or the “ Company ”) (TSX-V: MDX ) is pleased to announce that it is making an Application to the TSX-V for Acceptance of the proposed amendment to the terms of the currently outstanding Convertible Loan Notes (“ Series I Notes ”). Following the conversion of five Series I Loan Notes during 2021, there are currently 75 Series I Loan Notes... Read More

MISSISSAUGA, Ontario / Nov 21, 2023 / Business Wire / MedX Health Corp. (“ MedX ” or the “ Company ”) ( TSX-V: MDX ) is pleased to announce that, effective November 17, 2023, $2,965,000 of Secured Convertible Debentures were fully redeemed pursuant to exercise of the Conversion Rights by the Holders, resulting issuance of 59,300,000 common shares and 59,300,000 share purchase warrants exercisable at $0.20 until December 31,... Read More

MISSISSAUGA, Ontario / Nov 14, 2023 / Business Wire / MedX Health Corp. (“ MedX ” or the “ Company ”) (TSX-V: MDX) announced today that, it has submitted for Final Acceptance from the TSXV and has closed the non-brokered Private Placement which was previously announced on August 30, 2023. The placement, to accredited investors, raised $1,020,000 by issuance of 14,571,428 units at $0.07 per unit (“Unit”). Each Unit is... Read More

MISSISSAUGA, Ontario / Nov 01, 2023 / Business Wire / MedX Health Corp. (“MedX” or the “Company”) (TSXV: MDX ), a global leader in teledermatology, is pleased to announce the appointment of veteran healthcare industry leader Jeffrey Morris as Vice President of Sales and Marketing. With over 20 years of experience, Mr. Morris has worked for some of the most recognized global healthcare and pharmaceutical brands such as Pfizer... Read More

MISSISSAUGA, Ontario / Oct 12, 2023 / Business Wire / MedX Health Corp. (“ MedX ” or the “ Company ”) (TSX-V: MDX) announced today that, subject to acceptance by the TSX-V, the ultimate Closing Date for the non-brokered Private Placement of up to $1.5 million, which was previously announced on August 30, 2023, will be extended by up to 30 days. The Company has already received Conditional Acceptance for the placement from... Read More

MISSISSAUGA, Ontario / Aug 30, 2023 / Business Wire / MedX Health Corp. (“ MedX ” or the “ Company ”) (TSX-V: MDX ) is pleased to announce that it is proposing to raise up to $1,500,000 by way of a Non-Brokered Private Placement of up to 21,428,571 Units at $0.07 per Unit (“Unit”). Each Unit will be comprised of One (1) fully paid common share and One (1) Share Purchase Warrant, exercisable to purchase One (1) further Common... Read More

MISSISSAUGA, Ontario / Jun 19, 2023 / Business Wire / MedX Health Corp. (“ MedX ” or the “ Company ”) (TSXV: MDX ) is pleased to announce that it is making an Application to the TSX Venture Exchange for Acceptance of the proposed amendment to the terms of 17,495,472 share purchase warrants (“ Warrants ”) issued in April, May, and July 2020 in connection with Private Placements completed at that time. Pursuant to Acceptance... Read More

MISSISSAUGA, Ontario / May 10, 2023 / Business Wire / MedX Health Corp. (“MedX” or the “Company”) (TSXV: MDX) , a global leader in teledermatology, is pleased to announce that Stephen Lockyer has been appointed as Chief Executive Officer, effective immediately, in place of Naman Damaghlatrous, who has resigned both as an officer and director of the Company. “Stephen, who became a major investor in the company in recent... Read More

MISSISSAUGA, Ontario / Apr 25, 2023 / Business Wire / MedX Health Corp. ("MedX" or the "Company") (TSXV: MDX), a global leader in teledermatology, is pleased to announce changes to its Board of Directors. MedX welcomes two new members to its Board of Directors; Mr. Stephen Lockyer and Mr. Ed Ho, who both bring many years and wide-ranging business and entrepreneurial experience. Mr. Lockyer is the President and Owner of... Read More

PharmaChoice Canada, one of Canada’s fastest-growing pharmacy groups, with more than 1000 independent pharmacy owners and operators, announces its partnership with MedX Health to launch a pilot program of MedX’s DermSecure® Screening Platform MISSISSAUGA, Ontario / Apr 18, 2023 / Business Wire / MedX Health Corp. (" MedX " or the " Company ") (TSXV: MDX ), a global leader in teledermatology, is pleased to announce a... Read More

MISSISSAUGA, Ontario / Mar 20, 2023 / Business Wire / MedX Health Corp. (“ MedX ” or the “ Company ”) ( TSXV: MDX ), a global leader in teledermatology, is pleased to announce that it has completed the Final Closing of Secured Convertible Debentures previously announced in its Press Release dated January 30, 2023. The final Closing, which was completed on March 17, 2023, comprised issuance of five Secured Convertible... Read More

MISSISSAUGA, Ontario / Feb 15, 2023 / Business Wire / MedX Health Corp. (“ MedX ” or the “ Company ”) ( TSXV: MDX ), a global leader in teledermatology, is pleased to announce that it has completed the First Closing of Secured Convertible Debentures previously announced in its Press Release dated January 30, 2023. The first Closing comprised issuance of three Secured Convertible Debentures for a total of $765,000. Funds have... Read More

MISSISSAUGA, Ontario / Jan 30, 2023 / Business Wire / MedX Health Corp. (“ MedX ” or the “ Company ”) ( TSXV: MDX ), a global leader in teledermatology, is pleased to announce that it is proposing to complete a private placement financing to raise up to $1.5 million by issuance of one or more Secured Convertible Debentures. Proposed Secured Convertible Debenture Under the terms of the proposed placement, which is subject to... Read More

MedX Health Corp. (“ MedX ” or the “ Company ”) ( TSXV: MDX ), a global leader in teledermatology, is pleased to announce that, further to its Press Release dated November 18, 2022, it has closed a private placement financing to raise $1.5 million by issuance of a Secured Convertible Debenture (“ Convertible Debenture ”). Secured Convertible Debenture Under the terms of the Convertible Debenture, funding of $1.5 million has... Read More

MISSISSAUGA, Ontario--( BUSINESS WIRE )-- MedX Health Corp. (“ MedX ” or the “ Company ”) ( TSXV: MDX ), a global leader in teledermatology, is pleased to announce that it is proposing to complete a private placement financing to raise up to $1.5 million by issuance of a Secured Convertible Debenture. Proposed Secured Convertible Debenture Under the terms of the proposed placement, which is subject to Acceptance by the TSX... Read More